← Leaderboards
Julie Mitchell
Oregon Health & Science University
$648,380
Attributed
$648,380
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $412.2K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$648,380 · 2
By mechanism
R21$433,384 · 1
K01$214,996 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jonah B. Sacha$34,199,132
- Elinor L. Sullivan$13,925,205
- David C. Johnson$20,134,941
- Beth A Smith$8,164,945
- Brian K Jordan$818,558
Others in their field
Other Rising Stars on “Infant Infection”
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,735,864
- Michele Caggana · Nysdoh/Health Research, Inc.$4,856,614
- Amar Nijagal · University Of California, San Francisco$3,176,680
- Jennifer K Hoffman · Duke University$2,964,074
- Gary Lessing · Inovodel, Inc.$2,946,822
- Cassandra Cullin · Oregon Health & Science University$2,783,281
Research focus
Infant InfectionMorbidity - Disease RateHiv InfectionsInfantInsightLifeCharacteristicsFrequenciesImmuneImmune SystemDeath RateInfectionAdaptive Immune ResponseIn VitroAntiretroviral TherapyAge MonthsCellsCell Differentiation ProcessChildhoodChildImmune ResponseCohortAdultMortality
Grant awards (3)
Targeting Tfh differentiation to increase the magnitude and durability of antibody responses in infant rhesus macaques after SHIV infection$214,996
K01 · FY2025 · AI · contact PI
Persistence of HIV-specific CD8+ T cell responses after long-term ART in early treated Thai children$197,192
R21 · FY2025 · AI · contact PI
Persistence of HIV-specific CD8+ T cell responses after long-term ART in early treated Thai children$236,192
R21 · FY2024 · AI · contact PI